Cargando…
A Microbiota-Dependent Response to Anticancer Treatment in an In Vitro Human Microbiota Model: A Pilot Study With Hydroxycarbamide and Daunorubicin
BACKGROUND: Anticancer drug efficacy is linked to the gut microbiota’s composition, and there is a dire need to better understand these interactions for personalized medicine. In vitro microbiota models are promising tools for studies requiring controlled and repeatable conditions. We evaluated the...
Autores principales: | Hobson, Claire Amaris, Vigué, Lucile, Magnan, Mélanie, Chassaing, Benoit, Naimi, Sabrine, Gachet, Benoit, Claraz, Pauline, Storme, Thomas, Bonacorsi, Stephane, Tenaillon, Olivier, Birgy, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198576/ https://www.ncbi.nlm.nih.gov/pubmed/35719352 http://dx.doi.org/10.3389/fcimb.2022.886447 |
Ejemplares similares
-
MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment
por: Hobson, C A, et al.
Publicado: (2022) -
Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam
por: Hobson, Claire Amaris, et al.
Publicado: (2020) -
Direct impact of commonly used dietary emulsifiers on human gut microbiota
por: Naimi, Sabrine, et al.
Publicado: (2021) -
Local and Global Protein Interactions Contribute to Residue Entrenchment in Beta-Lactamase TEM-1
por: Birgy, André, et al.
Publicado: (2022) -
Not so Splendid for the Gut Microbiota
por: Chassaing, Benoit, et al.
Publicado: (2018)